Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meccellis Biotech manufactures CE-marked acellular dermal matrices from porcine dermis for surgical applications including breast reconstruction, general surgery, dental repairs, and parastomal hernia. Their CELLIS® line of products has been adopted by surgeons internationally. The company emphasizes high-quality biomaterials with exclusive processing to preserve natural structure and avoid preservatives. Clinical results support their use as effective alternatives to synthetic meshes or autologous grafts in indicated procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meccellis Biotech.